Skip to main content
. 2022 Nov 12;26(2):233–248. doi: 10.1007/s10456-022-09860-7

Fig. 3.

Fig. 3

Macrophage expression of CD11b and TIE2. A Multiplex immunohistochemistry depicts a diffuse infiltration of CD11b+ macrophages (red) in the perivascular connective tissue in COVID-19 hearts (COVID-19 patient ID 17), (cardiomyocytes green, nuclei blue), scale bar 100 µm. B Bar diagram showing relative infiltration of CD11b+ inflammatory cells in non-infected control (Ctrl), influenza (Inf), COVID-19 (CoV), and lymphocytic non-influenza myocarditis (Myo) heart specimens morphometrically assessed by multiplex immunohistochemistry (MPX). Cell counts are normalized to cells per mm2 tissue. C Immunohistochemical staining against TIE2 demonstrates the perivascular localization of TIE2+ cells (red arrowheads) in the myocardium of a COVID-19 patient (COVID-19 patient ID 17), scale bar: 10 µm. D Bar diagram showing the infiltration of Tie-2+ inflammatory cells in non-infected control (Ctrl), influenza (Inf), COVID-19 (CoV), and lymphocytic non-influenza myocarditis (Myo) heart specimens. Cell counts are normalized to cells per mm2 myocardial tissue. Due to the small sample size of lymphocytic non-influenza myocarditis and a high variance among the samples, no statistical tests for significance were carried out. COVID-19 specimens were subdivided into two cohorts of cases with a hospitalization time < 10d and > 10d. *p < 0.05, **p < 0.01, ***p < 0.001